131 related articles for article (PubMed ID: 2077417)
1. Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: confirmation by follow-up liver biopsy.
Onoyama K; Nakamura S; Yamamoto M; Kawadoko T; Nanishi F; Komoda T; Murai K; Fujishima M
Nephron; 1990; 56(3):325-8. PubMed ID: 2077417
[TBL] [Abstract][Full Text] [Related]
2. The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy.
Chan PC; Liu P; Cronin C; Heathcote J; Uldall R
Am J Kidney Dis; 1992 May; 19(5):484-9. PubMed ID: 1585939
[TBL] [Abstract][Full Text] [Related]
3. Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin.
De Marchi S; Cecchin E
Clin Sci (Lond); 1991 Jul; 81(1):113-21. PubMed ID: 1649718
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
Lazarus JM; Hakim RM; Newell J
Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644
[TBL] [Abstract][Full Text] [Related]
5. Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients.
Agroyannis B; Koutsicos D; Tzanatou-Exarchou H; Varsou-Papadimitriou E; Kapetanaki A; Yatzidis H
Int J Artif Organs; 1991 Jul; 14(7):403-6. PubMed ID: 1889892
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin treatment in haemodialysis patients with iron overload.
el-Reshaid K; Johny KV; Hakim A; Kamel H; Sebeta A; Hourani H; Kanyike FB
Acta Haematol; 1994; 91(3):130-5. PubMed ID: 8091934
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of hemosiderosis with regular phlebotomy and recombinant human erythropoietin. Case report and ferrokinetic studies.
Hotta T; Inoue C; Tsushita K; Miura Y; Saito H
Acta Haematol; 1991; 86(4):214-6. PubMed ID: 1805491
[TBL] [Abstract][Full Text] [Related]
9. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy.
McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP
J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306
[TBL] [Abstract][Full Text] [Related]
10. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
[TBL] [Abstract][Full Text] [Related]
11. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
13. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients.
Boelaert JR; Cantinieaux BF; Hariga CF; Fondu PG
Nephrol Dial Transplant; 1990; 5(7):504-17. PubMed ID: 2130296
[TBL] [Abstract][Full Text] [Related]
14. Secondary haemochromatosis in a haemodialysis patient.
Cheng L; Tang X; Fu P; Liu F
Singapore Med J; 2015 Jul; 56(7):e124-6. PubMed ID: 26243982
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in the erythropoietin era.
Robbins KC
Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
[TBL] [Abstract][Full Text] [Related]
16. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
[TBL] [Abstract][Full Text] [Related]
17. Overcoming barriers that inhibit proper treatment of anemia.
Agarwal R
Kidney Int Suppl; 2006 May; (101):S9-12. PubMed ID: 16830700
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
[TBL] [Abstract][Full Text] [Related]
19. Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy.
Bilgrami S; Bartolomeo A; Synnott V; Rickles FR
Acta Haematol; 1993; 89(3):141-3. PubMed ID: 8362602
[TBL] [Abstract][Full Text] [Related]
20. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
